To explore the mutation characteristics of H. pylori resistance‐related genes to antibiotics of
clarithromycin (CAM), levofloxacin (LVX) and metronidazole, 23SrRNA, gyrA, gyrB, rdxA …

Helicobacter pylori antibiotic susceptibility in the Dominican Republic has not been
monitored. We assessed H. pylori antibiotic susceptibility in the Dominican Republic, and …

Objective: Knowledge of local antibiotic resistance is crucial to the adaption of the effective
empirical first-line treatment for Helicobacter Pylori (H. pylori) infection. This study aimed to …

Background: Clarithromycin is a main component of the recommended first-line triple
therapy for Helicobacter pylori in Egypt. We aimed in our study to investigate the prevalence …

Helicobacter pylori is a gastric pathogen that is widely recognized as a causative agent of
gastric disease. Its eradication is variable, mainly due to increased resistance to …

Background-Antimicrobial resistance is the major factor leading to eradication failure in H.
pylori treatment. Molecular tests are useful to detect genetic mutations predictive of …

Introduction: Several genetic mutations affect the first-line triple therapy for Helicobacter
pylori. We aimed to study the most common genetic mutations affecting the metronidazole …

In this study, we evaluated the mutations of Helicobacter pylori associated with resistance to
clarithromycin and levofloxacin. Furthermore, based on the proposed interaction between …

In this chapter, the immense contribution of nucleic acid discovery to the diagnosis and
molecular epidemiology of pathogenic microorganisms and its relevance for veterinary and …

Significant progress has been obtained since the III Brazilian Consensus Conference on H.
pylori infection held in 2012, in Bento Gonçalves, Brazil, and justify a fourth meeting to …